Tcg Crossover Management, LLC Cabaletta Bio, Inc. Transaction History
Tcg Crossover Management, LLC
- $612 Million
- Q4 2024
A detailed history of Tcg Crossover Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 86,795 shares of CABA stock, worth $159,702. This represents 0.03% of its overall portfolio holdings.
Number of Shares
86,795
Previous 86,795
-0.0%
Holding current value
$159,702
Previous $409,000
53.55%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$8.75 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$7.5 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$6.69 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$5.28 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$5.08 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $53.4M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...